Company logo

OCGN - Ocugen, Inc.

NASDAQ -> Healthcare -> Biotechnology
Malvern, United States

OCGN price evolution
OCGN
Balance Sheet
(in millions $) 30 Jun 2021 31 Mar 2021 31 Dec 2020 30 Sep 2020
Current assets
Cash $115.79 $44.94 $24.19 $19.26
Short term investments
Net receivables
Inventory
Total current assets $121.63 $51.36 $25.88 $19.76
Long term investments
Property, plant & equipment $0.94 $0.76 $0.63 $0.21
Goodwill & intangible assets
Total noncurrent assets $2.63 $2.49 $1.5 $0.78
Total investments
Total assets $124.25 $53.85 $27.38 $20.54
Current liabilities
Accounts payable $0.8 $1.04 $0.4 $0.22
Deferred revenue
Short long term debt $0.17 $0.54 $0.28 $1.38
Total current liabilities $4.84 $4.28 $3.61 $4.13
Long term debt $3 $3.08 $2.21 $1.99
Total noncurrent liabilities $3 $3.08 $2.21 $1.99
Total debt $3.17 $3.62 $2.49 $3.36
Total liabilities $7.84 $7.36 $5.83 $6.12
Shareholders' equity
Retained earnings -$106.33 -$80.38 -$73.3 -$69.51
Other shareholder equity -$0.05 -$0.05 -$0.05 -$0.05
Total shareholder equity $116.41 $46.49 $21.55 $14.42
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $24.19 $7.6 $15.68 $7.22
Short term investments $0.9
Net receivables
Inventory
Total current assets $25.88 $15.77 $16.4 $8.18
Long term investments
Property, plant & equipment $0.63 $0.22 $0.14 $2.72
Goodwill & intangible assets
Total noncurrent assets $1.5 $1.04 $1.03 $2.86
Total investments $0.9
Total assets $27.38 $16.81 $17.43 $11.04
Current liabilities
Accounts payable $0.4 $1.9 $1.59 $0.78
Deferred revenue $10 $0.04
Short long term debt $0.28 $0.17 $0.18
Total current liabilities $3.61 $4.54 $2.87 $3.81
Long term debt $2.21 $1.24 $1.02
Total noncurrent liabilities $2.21 $1.25 $15.01 $18.5
Total debt $2.49 $1.41 $0.18
Total liabilities $5.83 $5.79 $17.89 $22.3
Shareholders' equity
Retained earnings -$73.3 -$51.48 -$216.83 -$208.19
Other shareholder equity -$0.05 -$0.05 $0
Total shareholder equity $21.55 $11.02 -$0.46 -$11.27
Income Statement
(in millions $) 30 Jun 2021 31 Mar 2021 31 Dec 2020 30 Sep 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $18.85 $2.87 $1.59 $1.48
Selling, general & administrative $6.76 $4.18 $2.21 $1.7
Total operating expenses $25.61 $7.06 $3.81 $10.18
Operating income -$25.61 -$7.06 -$3.81 -$10.18
Income from continuing operations
EBIT -$25.93 -$7.06 -$3.62 -$10.18
Income tax expense
Interest expense $0.02 $0.02 $0.17 $0.29
Net income
Net income -$25.95 -$7.08 -$3.79 -$10.47
Income (for common shares) -$25.95 -$7.08 -$3.79 -$10.47
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue $0.04
Cost of revenue
Gross Profit $0.04
Operating activities
Research & development $6.35 $8.09 $15.63 $15.57
Selling, general & administrative $7.97 $6.08 $10.2 $9.38
Total operating expenses $21.33 $14.16 $30.11 $24.95
Operating income -$21.28 -$14.16 -$30.11 -$24.95
Income from continuing operations
EBIT -$21.1 -$18.47 -$8.36 -$22.36
Income tax expense
Interest expense $0.72 $1.77 $0.16 $0.13
Net income
Net income -$21.82 -$20.24 -$8.52 -$22.5
Income (for common shares) -$34.37 -$20.24 -$8.52 -$22.5
Cash Flow
(in millions $) 30 Jun 2021 31 Mar 2021 31 Dec 2020 30 Sep 2020
Net income -$25.95 -$7.08 -$3.79 -$10.47
Operating activities
Depreciation $0.12 $0.11 $0.09 $0.07
Business acquisitions & disposals
Stock-based compensation $2.1 $0.83 $0.16 $0.13
Total cash flows from operations -$21.8 -$5.28 -$4.28 -$2.65
Investing activities
Capital expenditures -$0.26 -$0.26 -$0.25 -$0.02
Investments
Total cash flows from investing -$1.01 -$0.26 -$0.25 -$0.02
Financing activities
Dividends paid
Sale and purchase of stock $93.67 $26.3 $10.74 $10.04
Net borrowings -$0 -$0.01 -$1.27 -$3.23
Total cash flows from financing $93.66 $26.3 $9.47 $6.81
Effect of exchange rate
Change in cash and equivalents $70.85 $20.75 $4.93 $4.14
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income -$21.82 -$20.24 -$8.52 -$22.5
Operating activities
Depreciation $0.29 $0.31 $0.45 $1.53
Business acquisitions & disposals -$2.33
Stock-based compensation $0.66 $0.88 $1.63 $1.57
Total cash flows from operations -$14.71 -$16.89 -$15.78 -$23.02
Investing activities
Capital expenditures -$0.31 -$0.03 -$2.01 -$0.28
Investments $0.9 -$0.95
Total cash flows from investing -$0.31 -$2.36 -$1.11 -$1.23
Financing activities
Dividends paid
Sale and purchase of stock $36.34 $23.68 $25.53 $0.01
Net borrowings -$4.73 $1.38 -$0.18 -$0.58
Total cash flows from financing $31.61 $25.07 $25.35 -$0.58
Effect of exchange rate $0
Change in cash and equivalents $16.6 $5.82 $8.46 -$24.83
Fundamentals
Market cap $2.00B
Enterprise value $1.88B
Shares outstanding 198.76M
Revenue $0.00
EBITDA -$46.41M
EBIT -$46.80M
Net Income -$47.29M
Revenue Q/Q -100.00%
Revenue Y/Y -100.00%
P/E ratio -42.24
EV/Sales N/A
EV/EBITDA -40.61
EV/EBIT -40.28
P/S ratio N/A
P/B ratio 17.15
Book/Share 0.59
Cash/Share 0.58
EPS -$0.24
ROA -83.70%
ROE -95.12%
Debt/Equity 0.27
Net debt/EBITDA 2.33
Current ratio 25.13
Quick ratio 25.13